As of Feb 03, 2025, Oscar Health, Inc. Intrinsic Value is $25.2. This suggests it may be undervalued by 50.5% compared to its current price of around $16.8.
As of Feb 03, 2025, Oscar Health, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $16.8, using a discount rate of 10.8% and terminal growth rate of 3.0%.
Oscar Health, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $25.2, compared to a market price of around $16.8. This suggests a potential undervaluation of 50.5%.